AI Insight
Researchers have found evidence that serotonin, a neurotransmitter commonly associated with mood regulation and targeted by SSRI antidepressants, may play a role in amplifying tinnitus. Using optogenetics, a technique that employs light to control specific neurons in mice, the team identified a serotonin-driven neural circuit linked to tinnitus-like auditory behavior. These findings suggest a potential neurobiological mechanism that could explain why certain patients report increased ear ringing when taking serotonin-boosting medications.
Why it matters
This research could prompt clinicians to reconsider SSRI prescriptions for patients already experiencing tinnitus, and opens new avenues for developing targeted treatments that address the neural circuits involved in the condition without triggering auditory side effects.
Scientists have uncovered evidence that serotonin — the same brain chemical boosted by many antidepressants — may actually worsen tinnitus. Using advanced light-based brain stimulation in mice, researchers identified a serotonin-driven circuit linked directly to tinnitus-like behavior. The findings may explain why some people experience louder ringing in their ears while taking SSRIs.
Source: The brain’s “feel good” chemical may be secretly fueling tinnitus